EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ethnopharmacological relevance and anti-tuberculosis potential of selected Zingiber species: a critical evaluation of the evidence

A. S. Sinulingga, Y. Yuliandra, D. A. E. Pitaloka, S. Bhakta, R. A. Edrada-Ebel, N. F. Kurniati

Frontiers in Pharmacology · 19.11.2026 · 17

DOI: 10.3389/fphar.2026.1976528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.11.2026. Verfasst von A. S. Sinulingga und 5 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) remains a major global health problem, particularly with the continued emergence of drug-resistant Mycobacterium tuberculosis . Indonesia combines a high TB burden with extensive biodiversity and a long tradition of medicinal plant use, providing an important setting for ethnopharmacology-guided natural product research. Several Zingiber species used in Indonesian traditional medicine share respiratory-related indications, while more limited reports specifically describe their use for tuberculosis. This review critically evaluates the extent to which these ethnopharmacological observations are supported by experimental evidence relevant to TB and examines whether selected Zingiber taxa or their metabolites warrant further investigation as potential adjuncts to anti-TB therapy. Direct antimycobacterial activity has been reported for selected Zingiber preparations and metabolites, but the evidence varies substantially across mycobacterial models and study quality. Some preparations showed notable in vitro activity, whereas others were active only at high concentrations, and selectivity was frequently not assessed. Among individual metabolites, 6-gingerol has the broadest TB-specific experimental support, including drug-resistant isolates and in vivo infection models, although its reported potency varies across studies. Evidence for an adjunctive role is sparse. Selected metabolites have been reported to modify responses to anti-TB drugs, and 6-gingerol has been shown to reduce energy-dependent efflux in Staphylococcus aureus; however, direct evidence for efflux, resistance or drug-tolerance modulation in M. tuberculosis remains lacking. Pharmacokinetic interaction and unfavorable in vitro selectivity have also been reported for selected metabolites. Overall, the available evidence provides preliminary support for the anti-TB potential of selected Zingiber taxa and their metabolites, but remains too limited and heterogeneous to draw firm conclusions. An adjunctive role remains a hypothesis requiring further investigation, and its relevance to drug-resistant TB remains uncertain. Further studies using well-characterized botanical materials, clinically relevant mycobacterial models, selectivity assessment, and direct anti-TB drug-interaction studies are needed to determine their translational relevance.

Zitieren

APA

Sinulingga, A. S., Yuliandra, Y., Pitaloka, D. A. E., Bhakta, S., Edrada-Ebel, R. A., & Kurniati, N. F. (2026). Ethnopharmacological relevance and anti-tuberculosis potential of selected Zingiber species: a critical evaluation of the evidence. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1976528

Vancouver

Sinulingga AS, Yuliandra Y, Pitaloka DAE, Bhakta S, Edrada-Ebel RA, Kurniati NF. Ethnopharmacological relevance and anti-tuberculosis potential of selected Zingiber species: a critical evaluation of the evidence. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1976528

BibTeX
@article{Sinulingga2026,
  author = {Sinulingga, A. S. and Yuliandra, Y. and Pitaloka, D. A. E. and Bhakta, S. and Edrada-Ebel, R. A. and Kurniati, N. F.},
  title = {Ethnopharmacological relevance and anti-tuberculosis potential of selected Zingiber species: a critical evaluation of the evidence},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1976528}
}
Kostenlos starten →